NASDAQ:HSIC - Henry Schein Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$82.04 -0.47 (-0.57 %)
(As of 10/23/2018 02:27 AM ET)
Previous Close$82.51
Today's Range$81.66 - $83.0150
52-Week Range$62.56 - $90.52
Volume984,487 shs
Average Volume1.58 million shs
Market Capitalization$12.63 billion
P/E Ratio22.79
Dividend YieldN/A
Beta0.97
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides animal health products, such as branded and generic pharmaceuticals, surgical and consumable products and services, and equipment; and medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. The company was founded in 1932 and is headquartered in Melville, New York.

Receive HSIC News and Ratings via Email

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Medical & hospital equipment
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNASDAQ:HSIC
CUSIP80640710
Phone631-843-5500

Debt

Debt-to-Equity Ratio0.34
Current Ratio1.29
Quick Ratio0.68

Price-To-Earnings

Trailing P/E Ratio22.79
Forward P/E Ratio19.91
P/E Growth2.37

Sales & Book Value

Annual Sales$12.46 billion
Price / Sales1.01
Cash Flow$4.8344 per share
Price / Cash16.97
Book Value$18.00 per share
Price / Book4.56

Profitability

EPS (Most Recent Fiscal Year)$3.60
Net Income$406.29 million
Net Margins3.15%
Return on Equity20.40%
Return on Assets7.68%

Miscellaneous

Employees22,000
Outstanding Shares153,110,000
Market Cap$12.63 billion

Henry Schein (NASDAQ:HSIC) Frequently Asked Questions

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Shares of Henry Schein split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein declared that its board has initiated a stock repurchase plan on Tuesday, September 19th 2017, which permits the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 6.3% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) posted its quarterly earnings results on Monday, August, 6th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.01 by $0.03. The firm had revenue of $3.33 billion for the quarter, compared to analyst estimates of $3.31 billion. Henry Schein had a net margin of 3.15% and a return on equity of 20.40%. The firm's revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.88 earnings per share. View Henry Schein's Earnings History.

When is Henry Schein's next earnings date?

Henry Schein is scheduled to release their next quarterly earnings announcement on Monday, November 5th 2018. View Earnings Estimates for Henry Schein.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein updated its FY18 earnings guidance on Monday, August, 6th. The company provided earnings per share guidance of $4.06-4.14 for the period, compared to the Thomson Reuters consensus estimate of $4.11.

What price target have analysts set for HSIC?

19 analysts have issued 12-month price objectives for Henry Schein's shares. Their predictions range from $66.00 to $102.00. On average, they anticipate Henry Schein's stock price to reach $82.7222 in the next year. This suggests a possible upside of 0.8% from the stock's current price. View Analyst Price Targets for Henry Schein.

What is the consensus analysts' recommendation for Henry Schein?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 1 sell rating, 10 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Henry Schein.

What are Wall Street analysts saying about Henry Schein stock?

Here are some recent quotes from research analysts about Henry Schein stock:
  • 1. According to Zacks Investment Research, "In the past six months, Henry Schein has outperformed its industry. The company's operating segments recorded strong year-over-year growth in the last reported quarter. Strong share gain in the North America and overseas along with solid revenues is encouraging. Despite the better-than-expected revenue performance, we are disappointed with the year-over-year deterioration in gross and operating margin due to higher cost and expenses. We currently await the completion planned spin-off of the company’s global Animal Health business. This business contributes nearly 30% to the top line. The spin-off is expected to bring in major changes to Henry Schein’s overall operating results. On the flip side, pricing pressure and tough competition are major woes." (10/5/2018)
  • 2. Barrington Research analysts commented, "We are currently modeling $4.10. It is important to note that management’s adjusted EPS guidance does not include any impact from the upcoming animal health spin-off and merger, which is expected to occur before year end. In addition, the guidance does not factor in any future M&A activity." (8/7/2018)

Are investors shorting Henry Schein?

Henry Schein saw a decline in short interest in September. As of September 14th, there was short interest totalling 16,020,723 shares, a decline of 7.3% from the August 31st total of 17,291,234 shares. Based on an average trading volume of 1,103,270 shares, the short-interest ratio is presently 14.5 days. Approximately 10.6% of the shares of the stock are short sold. View Henry Schein's Current Options Chain.

Who are some of Henry Schein's key competitors?

Who are Henry Schein's key executives?

Henry Schein's management team includes the folowing people:
  • Mr. Stanley M. Bergman, Exec. Chairman & CEO (Age 68)
  • Mr. James P. Breslawski, Vice Chairman & Pres (Age 64)
  • Mr. Steven Paladino, Exec. VP, CFO & Exec. Director (Age 61)
  • Mr. Gerald A. Benjamin, Exec. VP, Chief Admin. Officer & Director (Age 65)
  • Mr. Robert Minowitz, Sr. VP of Global Dental Merchandising & Bus. Operations (Age 59)

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Longview Partners Guernsey LTD (8.92%), Swedbank (1.32%), Fenimore Asset Management Inc. (0.36%), Davis R M Inc. (0.29%), Bank of Montreal Can (0.27%) and Riverbridge Partners LLC (0.27%). Company insiders that own Henry Schein stock include Barry J Alperin, Donald J Kabat, Gerald A Benjamin, James A Harding, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Paul Brons, Paul Rose, Philip A Laskawy and Steven Paladino. View Institutional Ownership Trends for Henry Schein.

Which major investors are selling Henry Schein stock?

HSIC stock was sold by a variety of institutional investors in the last quarter, including Longview Partners Guernsey LTD, Swedbank, Davis R M Inc., Riverbridge Partners LLC, Neville Rodie & Shaw Inc., Gateway Investment Advisers LLC, Texas Permanent School Fund and Laurel Grove Capital LLC. Company insiders that have sold Henry Schein company stock in the last year include Barry J Alperin, Mark E Mlotek and Paul Brons. View Insider Buying and Selling for Henry Schein.

Which major investors are buying Henry Schein stock?

HSIC stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, CHURCHILL MANAGEMENT Corp, Andra AP fonden, Contravisory Investment Management Inc., Nisa Investment Advisors LLC, We Are One Seven LLC, Jaffetilchin Investment Partners LLC and Tandem Investment Advisors Inc.. View Insider Buying and Selling for Henry Schein.

How do I buy shares of Henry Schein?

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $82.04.

How big of a company is Henry Schein?

Henry Schein has a market capitalization of $12.63 billion and generates $12.46 billion in revenue each year. The company earns $406.29 million in net income (profit) each year or $3.60 on an earnings per share basis. Henry Schein employs 22,000 workers across the globe.

What is Henry Schein's official website?

The official website for Henry Schein is http://www.henryschein.com.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]


MarketBeat Community Rating for Henry Schein (NASDAQ HSIC)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  246 (Vote Outperform)
Underperform Votes:  442 (Vote Underperform)
Total Votes:  688
MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote "Outperform" if you believe HSIC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSIC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel